vs
Ingevity Corp（NGVT）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是Ingevity Corp的1.6倍（$303.4M vs $185.4M），Sotera Health Co净利率更高（11.5% vs -45.6%，领先57.1%），Ingevity Corp同比增速更快（36.7% vs 4.6%），Ingevity Corp自由现金流更多（$73.5M vs $52.4M），过去两年Sotera Health Co的营收复合增速更高（10.6% vs -26.2%）
Ingevity Corp是一家全球特种化学品与先进材料生产商，主营高性能碳材料、路面养护解决方案及特种化工产品，服务汽车排放控制、工业净化、道路基建、农业投入品等核心市场，业务覆盖北美、欧洲及亚太地区。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
NGVT vs SHC — 直观对比
营收规模更大
SHC
是对方的1.6倍
$185.4M
营收增速更快
NGVT
高出32.2%
4.6%
净利率更高
SHC
高出57.1%
-45.6%
自由现金流更多
NGVT
多$21.1M
$52.4M
两年增速更快
SHC
近两年复合增速
-26.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.4M | $303.4M |
| 净利润 | $-84.6M | $34.8M |
| 毛利率 | 41.2% | 54.7% |
| 营业利润率 | -47.7% | 23.2% |
| 净利率 | -45.6% | 11.5% |
| 营收同比 | 36.7% | 4.6% |
| 净利润同比 | -609.6% | 182.8% |
| 每股收益（稀释后） | $-2.33 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NGVTSHC
| Q4 25 | $185.4M | $303.4M | ||
| Q3 25 | $333.1M | $311.3M | ||
| Q2 25 | $365.1M | $294.3M | ||
| Q1 25 | $284.0M | $254.5M | ||
| Q4 24 | $135.6M | $290.2M | ||
| Q3 24 | $333.8M | $285.5M | ||
| Q2 24 | $390.6M | $276.6M | ||
| Q1 24 | $340.1M | $248.2M |
净利润NGVTSHC
| Q4 25 | $-84.6M | $34.8M | ||
| Q3 25 | $43.5M | $48.4M | ||
| Q2 25 | $-146.5M | $8.0M | ||
| Q1 25 | $20.5M | $-13.3M | ||
| Q4 24 | $16.6M | $12.3M | ||
| Q3 24 | $-107.2M | $17.0M | ||
| Q2 24 | $-283.7M | $8.8M | ||
| Q1 24 | $-56.0M | $6.3M |
毛利率NGVTSHC
| Q4 25 | 41.2% | 54.7% | ||
| Q3 25 | 40.2% | 57.0% | ||
| Q2 25 | 37.8% | 56.6% | ||
| Q1 25 | 39.9% | 53.2% | ||
| Q4 24 | 81.3% | 56.6% | ||
| Q3 24 | 39.4% | 55.4% | ||
| Q2 24 | 31.5% | 55.2% | ||
| Q1 24 | 29.3% | 51.2% |
营业利润率NGVTSHC
| Q4 25 | -47.7% | 23.2% | ||
| Q3 25 | 18.7% | 23.4% | ||
| Q2 25 | -39.1% | 6.4% | ||
| Q1 25 | 9.4% | -5.8% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | 33.0% | 28.2% | ||
| Q2 24 | 25.9% | 27.8% | ||
| Q1 24 | 22.6% | 21.4% |
净利率NGVTSHC
| Q4 25 | -45.6% | 11.5% | ||
| Q3 25 | 13.1% | 15.5% | ||
| Q2 25 | -40.1% | 2.7% | ||
| Q1 25 | 7.2% | -5.2% | ||
| Q4 24 | 12.2% | 4.2% | ||
| Q3 24 | -32.1% | 6.0% | ||
| Q2 24 | -72.6% | 3.2% | ||
| Q1 24 | -16.5% | 2.5% |
每股收益（稀释后）NGVTSHC
| Q4 25 | $-2.33 | $0.12 | ||
| Q3 25 | $1.18 | $0.17 | ||
| Q2 25 | $-4.02 | $0.03 | ||
| Q1 25 | $0.56 | $-0.05 | ||
| Q4 24 | $0.44 | $0.05 | ||
| Q3 24 | $-2.94 | $0.06 | ||
| Q2 24 | $-7.81 | $0.03 | ||
| Q1 24 | $-1.54 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.1M | $344.6M |
| 总债务越低越好 | $1.2B | $2.1B |
| 股东权益账面价值 | $29.7M | $606.0M |
| 总资产 | $1.7B | $3.3B |
| 负债/权益比越低杠杆越低 | 39.10× | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资NGVTSHC
| Q4 25 | $78.1M | $344.6M | ||
| Q3 25 | $83.4M | $299.2M | ||
| Q2 25 | $76.9M | $332.4M | ||
| Q1 25 | $71.5M | $304.4M | ||
| Q4 24 | $68.0M | $277.2M | ||
| Q3 24 | $135.5M | $306.7M | ||
| Q2 24 | $107.4M | $246.1M | ||
| Q1 24 | $88.5M | $261.1M |
总债务NGVTSHC
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $1.3B | $2.2B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.4B | $2.2B | ||
| Q2 24 | $1.4B | $2.2B | ||
| Q1 24 | $1.4B | $2.2B |
股东权益NGVTSHC
| Q4 25 | $29.7M | $606.0M | ||
| Q3 25 | $138.1M | $550.5M | ||
| Q2 25 | $120.7M | $511.3M | ||
| Q1 25 | $234.6M | $414.1M | ||
| Q4 24 | $195.2M | $404.9M | ||
| Q3 24 | $214.5M | $470.2M | ||
| Q2 24 | $284.8M | $422.8M | ||
| Q1 24 | $568.2M | $429.4M |
总资产NGVTSHC
| Q4 25 | $1.7B | $3.3B | ||
| Q3 25 | $1.8B | $3.2B | ||
| Q2 25 | $1.9B | $3.2B | ||
| Q1 25 | $2.1B | $3.1B | ||
| Q4 24 | $2.0B | $3.1B | ||
| Q3 24 | $2.2B | $3.1B | ||
| Q2 24 | $2.3B | $3.1B | ||
| Q1 24 | $2.6B | $3.1B |
负债/权益比NGVTSHC
| Q4 25 | 39.10× | 3.53× | ||
| Q3 25 | 8.39× | 3.89× | ||
| Q2 25 | 10.24× | 4.34× | ||
| Q1 25 | 5.68× | 5.36× | ||
| Q4 24 | 6.86× | 5.49× | ||
| Q3 24 | 6.52× | 4.73× | ||
| Q2 24 | 4.92× | 5.26× | ||
| Q1 24 | 2.48× | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $97.1M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $73.5M | $52.4M |
| 自由现金流率自由现金流/营收 | 39.6% | 17.3% |
| 资本支出强度资本支出/营收 | 12.7% | 16.7% |
| 现金转化率经营现金流/净利润 | — | 2.96× |
| 过去12个月自由现金流最近4个季度 | $273.5M | $149.2M |
8季度趋势，按日历期对齐
经营现金流NGVTSHC
| Q4 25 | $97.1M | $103.1M | ||
| Q3 25 | $129.7M | $71.2M | ||
| Q2 25 | $79.0M | $57.4M | ||
| Q1 25 | $25.4M | $55.5M | ||
| Q4 24 | $64.5M | $55.7M | ||
| Q3 24 | $46.5M | $97.5M | ||
| Q2 24 | $29.7M | $61.3M | ||
| Q1 24 | $-12.1M | $9.7M |
自由现金流NGVTSHC
| Q4 25 | $73.5M | $52.4M | ||
| Q3 25 | $117.8M | $35.0M | ||
| Q2 25 | $66.8M | $26.2M | ||
| Q1 25 | $15.4M | $35.6M | ||
| Q4 24 | $39.6M | $-10.2M | ||
| Q3 24 | $28.5M | $61.1M | ||
| Q2 24 | $11.6M | $19.4M | ||
| Q1 24 | $-28.7M | $-25.2M |
自由现金流率NGVTSHC
| Q4 25 | 39.6% | 17.3% | ||
| Q3 25 | 35.4% | 11.2% | ||
| Q2 25 | 18.3% | 8.9% | ||
| Q1 25 | 5.4% | 14.0% | ||
| Q4 24 | 29.2% | -3.5% | ||
| Q3 24 | 8.5% | 21.4% | ||
| Q2 24 | 3.0% | 7.0% | ||
| Q1 24 | -8.4% | -10.2% |
资本支出强度NGVTSHC
| Q4 25 | 12.7% | 16.7% | ||
| Q3 25 | 3.6% | 11.6% | ||
| Q2 25 | 3.3% | 10.6% | ||
| Q1 25 | 3.5% | 7.8% | ||
| Q4 24 | 18.4% | 22.7% | ||
| Q3 24 | 5.4% | 12.7% | ||
| Q2 24 | 4.6% | 15.2% | ||
| Q1 24 | 4.9% | 14.1% |
现金转化率NGVTSHC
| Q4 25 | — | 2.96× | ||
| Q3 25 | 2.98× | 1.47× | ||
| Q2 25 | — | 7.21× | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 3.89× | 4.52× | ||
| Q3 24 | — | 5.73× | ||
| Q2 24 | — | 7.00× | ||
| Q1 24 | — | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVT
| Performance Materials | $151.2M | 82% |
| Advanced Polymer Technologies Segment | $36.5M | 20% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
